Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY® study
Martin Prázný, Milos Aleksandric(Boehringer Ingelheim (Austria)), Alexey Medvedchikov(Boehringer Ingelheim (Austria)), Л. А. Суплотова(Tyumen State Medical University), Zdravko Kamenov(Medical University of Sofia), Tibor Fülöp(Medical University of South Carolina), Janusz Gumprecht(Medical University of Silesia), Doron Rosenzweig(Boehringer Ingelheim (Austria))
Cited by 11
Related Papers
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults)
|Obesity and metabolism|2018|167
A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider
|Patient Preference and Adherence|2022|156
Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study
|Molecular Psychiatry|2014|129
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
|Obesity and metabolism|2021|123